AnaptysBio

AnaptysBio is a clinical-stage biotechnology company headquartered in San Diego, California. The company employs 150 people and generated $52.9 million in revenue. AnaptysBio focuses on discovering and developing innovative immunology therapeutics, specializing in immune cell modulators. Their portfolio includes two checkpoint agonists currently in clinical trials. These therapies are designed to address the needs of patients suffering from autoimmune and inflammatory diseases. AnaptysBio distinguishes itself through its commitment to transforming patient health by developing groundbreaking immunology treatments. Their dedication to research and development in the field of immune cell modulation sets them apart as a leader in the pursuit of innovative solutions for challenging diseases. For more information about AnaptysBio and their work, please visit their website at anaptysbio.com.

AnaptysBio, Inc. is a clinical-stage biotechnology company. It focuses on developing innovative immunology therapeutics for autoimmune and inflammatory diseases. The company is located in San Diego, CA, with its address at 10770 Wateridge Circle Suite 210, 92121-5801. AnaptysBio operates within the healthcare, biotechnology, and pharmaceuticals industries. AnaptysBio's lead program is rosnilimab, which is in Phase 2b trials for rheumatoid arthritis and Phase 2 trials for ulcerative colitis. The company also has a pipeline that includes ANB033 and ANB101, both of which are in Phase 1 trials. AnaptysBio targets the healthcare, biotechnology, and pharmaceutical industries. The company's competitive advantages include over 20 years of operating and advisory experience in the life sciences industry. AnaptysBio also has a diverse and experienced board of directors and senior leadership. Furthermore, the company develops best-in-class immune cell modulators designed to restore healthy immune function. AnaptysBio's values include transparency, accountability, and humility. The company can be contacted via phone at (858) 362-6295 or through various email addresses, including [email protected], [email protected], [email protected], [email protected], and [email protected]. Key personnel include Daniel Faga, President & CEO; Ben Stone, Chief Business Officer; and Paul F. Lizzul, M.D., Ph.D., M.P.H, M.B.A., Chief Medical Officer.